NantHealth Inc (NYSE:NH) reported Q2 2017 earnings this Afternoon, coming in at ($0.18) per share, missing Wall Street’s estimates of ($0.15) per Share. Revenue for the quarter came in at $26.23 million missing the streets estimates of $31.28 million
Analyst Coverage For NantHealth Inc (NYSE:NH)
These are 4 Buy Ratings .
The current consensus rating for NantHealth Inc (NYSE:NH) is Buy (Score: 3.00) with a consensus target price of $10.38 , a potential (156.17% upside)
Recent Trading for NantHealth Inc (NYSE:NH) Shares of NantHealth Inc closed the previous trading session at 4.05 up +0.09 2.27% with 227,358 shares trading hands.